PDT Partners’s Compugen CGEN Stock Holding History

PDT Partners’s Portfolio CGEN Stock Details CGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-178,334	Closed	-$574K	–	976
2022 Q1	$574K	Sell	178,334 -41,749	-19%	-$141K	0.05%	537
2021 Q4	$946K	Buy	220,083 +78,883	+56%	+$427K	0.07%	371
2021 Q3	$843K	Hold	141,200	–	–	0.06%	379
2021 Q2	$1.17M	Sell	141,200 -113,426	-45%	-$921K	0.08%	348
2021 Q1	$2.19M	Sell	254,626 -19,029	-7%	-$211K	0.16%	253
2020 Q4	$3.31M	Buy	273,655 +14,055	+5%	+$194K	0.22%	188
2020 Q3	$4.22M	Buy	259,600 +130,144	+101%	+$2.13M	0.28%	147
2020 Q2	$1.94M	Buy	129,456 +96,856	+297%	+$1.31M	0.13%	215
2020 Q1	$237K	Buy	32,600 +13,900	+74%	+$109K	0.02%	525
2019 Q4	$111K	Buy	+18,700	New	+$96.2K	0.01%	686

Other funds holding CGEN

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

TFCM

Taylor Frigon Capital Management Scottsdale, Arizona $176M AUM 24.25% 1-Year Est. Return

PDT Partners's CGEN Position: Q2 2022 in Review

PDT Partners sold out of Compugen (CGEN) in Q2 2022, closing a stake of 178,334 shares — an estimated $574K sold.

PDT Partners first reported a position in CGEN in Q4 2019 and held it in 10 quarters. The position peaked at $4.22M in Q3 2020. 89 funds tracked by Wall St. Rank hold CGEN as of Q2 2022.

PDT Partners reported no remaining Compugen position as of Q2 2022 after selling out during the quarter.
PDT Partners sold 178,334 Compugen shares in Q2 2022, an estimated $574K.
PDT Partners first reported a position in Compugen in Q4 2019 and held it in 10 quarters.
PDT Partners's Compugen position peaked at $4.22M in Q3 2020.
89 funds tracked by Wall St. Rank held Compugen as of Q2 2022.

Based on PDT Partners's 13F filing for Q2 2022, filed 15 Aug 2022.